01- New Valvular Heart Disease Guidelines with Key TAVI and Mitral Regurgitation Updates
Valvular heart disease management guidelines were updated last week by the AHA and the ACC.
Read more HERE
02- High Risk Anatomy Challenges ISCHEMIA Outcomes
According to this recent analysis published in JAHA, patients with stable Ischemic heart disease and high-risk anatomy benefit from revascularization at long term vs. the conservative treatment.
Read more HERE
03- N95 and Surgical Face Mask Sterilization Is Feasible
This study shows re-sterilization of N95 and KN95 surgical face masks is indeed feasible, though not all techniques will render the same results and not all protection elements will keep filtration capacity.
Read more HERE
04- Pending Challenges in Transradial Access
The recent SAFARI-STEMI study compared transradial and femoral access in patients with ST-segment elevation myocardial infarction, and no significant differences were found. These results have a sour taste for those in favor of transradial access, as they are convinced of its benefits and unwilling to go back to previous practices.
Read more HERE
05- More Evidence for Short Term DAPT: Approaching “the Class Effect”
Patients at high risk of bleeding undergoing coronary angioplasty with Orsiro stent can be considered for a short dual antiplatelet scheme.
Read more HERE
06- Diabetes and Peripheral Vascular Disease: Old Drugs, New Evidence
This paper, recently published in JAHA, showed that patients with type 2 diabetes mellitus exhibiting lower-limb vascular disease benefit from combining cilostazol and clopidogrel.
Read more HERE
07- Optimal Medical Treatment Under-used in Vascular Peripheral Disease
Less than half of patients undergoing endovascular revascularization for peripheral artery disease to their lower limbs are discharged with optimal medical treatment.
Read more HERE
08- Pleiotropic Effect of Metoprolol: Different From other B-blockers
The clinical practice guidelines recommend the early use of endovenous B-blockers in patients undergoing acute myocardial MI, taking for granted that all B-blockers have a similar class effect.
Read more HERE
09- Latest News on AHA/ACC Primary Prevention Guidelines
Most cardiovascular diseases and mortality come down to 4 years of unhealthy habits (smoking, poor diet, obesity and sedentarism) and 3 major risk factors (cholesterol, hypertension, and diabetes).
Read more HERE
10- Axillary Access for Microaxial Ventricular Support Device Placement
There is little evidence in support of the axillary access for counterpulsation balloon insertion, but this evidence is null when it comes to microaxial ventricular support device placement (the Impella device family).
Read more HERE
Subscribe to our weekly newsletter
Get the latest scientific articles on interventional cardiology
